- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04182412
Abdominal Rectus Diastasis (ARD) Reconstruction (ARD)
October 2, 2023 updated by: Anders Thorell, Karolinska Institutet
Minimally Invasive Abdominal Wall Reconstruction in Symptomatic Rectus Diastasis
The aim of this study is to investigate whether abdominal wall reconstruction through laparoscopic surgery can be recommended as a safe treatment alternative for patients with symptomatic rectus diastasis, and if this type of treatment leads to improved quality of life, trunk stability and reduced pain.
Study Overview
Detailed Description
Investigate whether surgical reconstruction with laparoscopic technique can lead to improved quality of Life, trunk stability and reduced pain in patients with symptomatic rectus diastasis.
The study will also compare two different laparoscopic surgery methods for abdominal wall reconstruction: narrowing of linea alba with continuous suture with or without mesh.
Study Type
Interventional
Enrollment (Estimated)
110
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Anders Thorell, Professor
- Phone Number: +46 8 714 6541
- Email: anders.thorell@erstadiakoni.se
Study Locations
-
-
Region Stockholm
-
Stockholm, Region Stockholm, Sweden, SE-116 91
- Recruiting
- Karolinska Institutet, Ersta Hospital
-
Contact:
- Anders Thorell, professor
- Phone Number: 6541 +46 (0) 8 7146541
- Email: anders.thorell@erstadiakoni.se
-
Principal Investigator:
- Anders Thorell, Ass. Prof.
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Rectus diastasis ≥3 cm
- BMI =<28 kg/m2
- non smoker
- abdominal instability,
- abdominal wall and/or lower back pain despite physical therapy / structured physical exercise for at least 6 months
Exclusion Criteria:
- BMI >28 kg/m2
- Smoking
- Ongoing immunosuppressive therapy
- Current pregnancy ≥16 weeks gestational age for the last 12 months
- Pregnant or women who wish to become pregnant
- Previously extensive abdominal wall surgery incl hernia surgery (NOT including sectio, appendectomy, small umbilical herniae)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Suture
laparoscopic narrowing of linea alba with continuous suture
|
surgical reconstruction with laparoscopic technique
|
Active Comparator: suture and mesh
narrowing of linea alba with continuous suture and mesh
|
surgical reconstruction with laparoscopic technique
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Rate of recurrence
Time Frame: 1 year
|
computed tomography
|
1 year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Visual Analog Pain Scale (VAS)
Time Frame: 1 year, 3 years
|
Scale from 0 to 10, where 0 is no pain and 10 is the worst possible pain
|
1 year, 3 years
|
Abdominal stability
Time Frame: 1 year, 3 years
|
patient self-esteem by one question; do you feel that the instability of the abdominal wall has disappeared, yes/no/partially
|
1 year, 3 years
|
SF-36 Quality of Life instrument
Time Frame: 1 year, 3 years
|
The RAND-36 It is comprised of 36 items that assess eight health concepts: physical functioning, role limitations caused by physical health problems, role limitations caused by emotional problems, social functioning, emotional well-being, energy/fatigue, pain, and general health perceptions.
Physical and mental health summary scores are also derived from the eight RAND-36 scales.
Higher scores mean a better outcome.
|
1 year, 3 years
|
VHPQ is a questionnaire for the assessment of pre- and postoperative pain
Time Frame: 1 year, 3 years
|
The questionnaire comprises 20 questions The first six questions concern the level and duration of pain.
The next seven questionsrelate to the impact on daily activities.
The final questions deal with patient satisfaction and how physically demanding the patients regard their occupation.
Pain intensity in the VHPQ is assessed using a 7-step fixed-point rating scale with steps linked to pain behavior rather than numbers or verbal descriptors of pain.
Higher scores mean a worse outcome.
|
1 year, 3 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Anders Thorell, Professor, Karolinska Institutet
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 17, 2019
Primary Completion (Estimated)
December 31, 2027
Study Completion (Estimated)
December 31, 2027
Study Registration Dates
First Submitted
November 7, 2019
First Submitted That Met QC Criteria
November 28, 2019
First Posted (Actual)
December 2, 2019
Study Record Updates
Last Update Posted (Actual)
October 4, 2023
Last Update Submitted That Met QC Criteria
October 2, 2023
Last Verified
October 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2019-01959
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Rectus Diastasis
-
Umeå UniversityRecruitingAbdominal Rectus DiastasisSweden
-
NeuFit - Neurological Fitness and EducationUniversity of Texas at AustinWithdrawnRectus DiastasisUnited States
-
Pavol Jozef Safarik UniversityCompletedDiastasis of m. Rectus AbdominisSlovakia
-
Karolinska InstitutetStockholm South General HospitalCompletedRectus Abdominus; Diastasis, Complicating Delivery
-
Cairo UniversityCompleted
-
Tampere University HospitalCompletedSubcutaneous Abdominal Fat | Abdominal Skin Elasticity | Rectus Muscle Diastasis | Unpleasant Body Contour
-
AZ AlmaCompleted
-
University of Castilla-La ManchaNot yet recruitingDiastasis Recti | Diastasis Recti and Weakness of the Linea Alba | Diastasis Recti Abdominis | Diastasis
-
Norwegian School of Sport SciencesThe Norwegian Women´s Public Health AssociationCompletedDiastasis Recti | Diastasis Recti AbdominisNorway
Clinical Trials on ARD
-
Aardvark Therapeutics, Inc.Children's Hospital Colorado; Stanford UniversityRecruiting
-
Ardana Bioscience LtdCompleted
-
Aardvark Therapeutics, Inc.Center for Psychiatry And Behavioral Medicine Inc.RecruitingAutism Spectrum DisorderUnited States
-
Ardana Bioscience LtdCompleted
-
Ardana Bioscience LtdTerminatedHypogonadismUnited States
-
Aardvark Therapeutics, Inc.University of California, San DiegoCompletedObesity | Weight Gain | Bariatric SurgeryUnited States
-
Hillel Yaffe Medical CenterCompletedUnfavorable Cervix for Induction of LaborIsrael
-
William Beaumont HospitalsTeleflexCompletedCatheter Infection | Catheter Complications | Catheter ThrombosisUnited States
-
Aardvark Therapeutics, Inc.University of California, San DiegoCompleted
-
University of MalayaTeleflexRecruitingCLABSI - Central Line Associated Bloodstream InfectionMalaysia